BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38547690)

  • 1. Mucin 1 and venous thrombosis in tumor-bearing mice and patients with cancer.
    Kawano T; Englisch C; Hisada Y; Paul D; Archibald S; Grover S; Pabinger I; Ay C; Mackman N
    Thromb Res; 2024 May; 237():23-30. PubMed ID: 38547690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?
    Tesselaar ME; Romijn FP; Van Der Linden IK; Prins FA; Bertina RM; Osanto S
    J Thromb Haemost; 2007 Mar; 5(3):520-7. PubMed ID: 17166244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
    Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N
    J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer cell-derived tissue factor-positive extracellular vesicles: biomarkers of thrombosis and survival.
    Hisada Y; Mackman N
    Curr Opin Hematol; 2019 Sep; 26(5):349-356. PubMed ID: 31261175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer.
    Wu G; Kim D; Kim JN; Park S; Maharjan S; Koh H; Moon K; Lee Y; Kwon HJ
    Theranostics; 2018; 8(1):78-91. PubMed ID: 29290794
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer-associated fibroblasts promote venous thrombosis through podoplanin/CLEC-2 interaction in podoplanin-negative lung cancer mouse model.
    Shirai T; Tsukiji N; Sasaki T; Oishi S; Yokomori R; Takano K; Suzuki-Inoue K
    J Thromb Haemost; 2023 Nov; 21(11):3153-3165. PubMed ID: 37473844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Monoclonal Antibody Targets Mucin1 and Attenuates Growth in Pancreatic Cancer Model.
    Wu G; Maharjan S; Kim D; Kim JN; Park BK; Koh H; Moon K; Lee Y; Kwon HJ
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29987260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models.
    Hisada Y; Mackman N
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):182-186. PubMed ID: 31808871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred.
    Mukherjee P; Ginardi AR; Madsen CS; Sterner CJ; Adriance MC; Tevethia MJ; Gendler SJ
    J Immunol; 2000 Sep; 165(6):3451-60. PubMed ID: 10975866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
    Yonezawa S; Sato E
    Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of a novel MUC1 antibody to identify cancer stem cells and circulating MUC1 in mice and patients with pancreatic cancer.
    Curry JM; Thompson KJ; Rao SG; Besmer DM; Murphy AM; Grdzelishvili VZ; Ahrens WA; McKillop IH; Sindram D; Iannitti DA; Martinie JB; Mukherjee P
    J Surg Oncol; 2013 Jun; 107(7):713-22. PubMed ID: 23335066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms.
    Gomes FG; Sandim V; Almeida VH; Rondon AMR; Succar BB; Hottz ED; Leal AC; Verçoza BRF; Rodrigues JCF; Bozza PT; Zingali RB; Monteiro RQ
    Thromb Res; 2017 Nov; 159():24-32. PubMed ID: 28950217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-glycosylation of MUC1 mucin in prostate cancer and the effects of its expression on tumor growth in a prostate cancer xenograft model.
    Premaratne P; Welén K; Damber JE; Hansson GC; Bäckström M
    Tumour Biol; 2011 Feb; 32(1):203-13. PubMed ID: 20872286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer.
    Hisada Y; Garratt KB; Maqsood A; Grover SP; Kawano T; Cooley BC; Erlich J; Moik F; Flick MJ; Pabinger I; Mackman N; Ay C
    Blood Adv; 2021 Jan; 5(2):487-495. PubMed ID: 33496742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition.
    Roy LD; Sahraei M; Subramani DB; Besmer D; Nath S; Tinder TL; Bajaj E; Shanmugam K; Lee YY; Hwang SI; Gendler SJ; Mukherjee P
    Oncogene; 2011 Mar; 30(12):1449-59. PubMed ID: 21102519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.
    Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA
    Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel humanized MUC1 antibody-drug conjugate for the treatment of trastuzumab-resistant breast cancer.
    Wu G; Li L; Qiu Y; Sun W; Ren T; Lv Y; Liu M; Wang X; Tao H; Zhao L; Cao J; He L; Li H; Gu H
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1625-1639. PubMed ID: 34586349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors.
    Hisada Y; Grover SP; Maqsood A; Houston R; Ay C; Noubouossie DF; Cooley BC; Wallén H; Key NS; Thålin C; Farkas ÁZ; Farkas VJ; Tenekedjiev K; Kolev K; Mackman N
    Haematologica; 2020 Jan; 105(1):218-225. PubMed ID: 31048354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of MUC1 biosynthesis via threonyl-tRNA synthetase suppresses pancreatic cancer cell migration.
    Jeong SJ; Kim JH; Lim BJ; Yoon I; Song JA; Moon HS; Kim D; Lee DK; Kim S
    Exp Mol Med; 2018 Jan; 50(1):e424. PubMed ID: 29328069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells.
    Tréhoux S; Lahdaoui F; Delpu Y; Renaud F; Leteurtre E; Torrisani J; Jonckheere N; Van Seuningen I
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2392-403. PubMed ID: 26036346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.